RU2018144043A3 - - Google Patents

Download PDF

Info

Publication number
RU2018144043A3
RU2018144043A3 RU2018144043A RU2018144043A RU2018144043A3 RU 2018144043 A3 RU2018144043 A3 RU 2018144043A3 RU 2018144043 A RU2018144043 A RU 2018144043A RU 2018144043 A RU2018144043 A RU 2018144043A RU 2018144043 A3 RU2018144043 A3 RU 2018144043A3
Authority
RU
Russia
Application number
RU2018144043A
Other versions
RU2018144043A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018144043A publication Critical patent/RU2018144043A/ru
Publication of RU2018144043A3 publication Critical patent/RU2018144043A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
RU2018144043A 2016-05-13 2017-05-12 Кристаллы RU2018144043A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662336549P 2016-05-13 2016-05-13
US62/336,549 2016-05-13
US201662336652P 2016-05-14 2016-05-14
US62/336,652 2016-05-14
PCT/US2017/032563 WO2017197371A1 (en) 2016-05-13 2017-05-12 Crystals

Publications (2)

Publication Number Publication Date
RU2018144043A RU2018144043A (ru) 2020-06-15
RU2018144043A3 true RU2018144043A3 (ru) 2021-02-17

Family

ID=60266783

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018144043A RU2018144043A (ru) 2016-05-13 2017-05-12 Кристаллы

Country Status (13)

Country Link
US (3) US11117909B2 (ru)
EP (1) EP3454846A4 (ru)
JP (2) JP2019521086A (ru)
KR (2) KR20230173224A (ru)
CN (2) CN109475516A (ru)
AU (1) AU2017261828B2 (ru)
BR (1) BR112018073424A2 (ru)
CA (1) CA3022684A1 (ru)
IL (1) IL262674A (ru)
MX (1) MX2018013937A (ru)
RU (1) RU2018144043A (ru)
TW (1) TWI750169B (ru)
WO (1) WO2017197371A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2699646T3 (es) 2012-05-08 2019-02-12 Aeromics Inc Compuestos para uso en el tratamiento de enfermedades mediadas por acuaporina
RU2691951C2 (ru) 2013-11-06 2019-06-19 Аэромикс, Инк. Новые составы
CN110790787B (zh) * 2019-11-12 2022-06-14 广东药科大学 一类水溶性前药、其制备方法及其作为药物的用途
MX2023001493A (es) * 2020-08-05 2023-06-23 Jiangsu Simcere Pharm Co Ltd Composicion farmaceutica de un inhibidor de la acuaporina y metodo para la preparacion de la misma.
CN115504902A (zh) * 2021-06-22 2022-12-23 广东药科大学 5-氯水杨酰胺类衍生物、其制备方法及其作为药物的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ220764A (en) 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
JP3253131B2 (ja) 1992-07-24 2002-02-04 洋巳 和田 移植臓器用溶液
WO2003103656A1 (ja) * 2002-06-06 2003-12-18 株式会社医薬分子設計研究所 O−置換ヒドロキシアリール誘導体
US20130177017A1 (en) * 2012-01-06 2013-07-11 David Charles Elliott Method and apparatus for reflective memory
ES2699646T3 (es) 2012-05-08 2019-02-12 Aeromics Inc Compuestos para uso en el tratamiento de enfermedades mediadas por acuaporina
RU2691951C2 (ru) 2013-11-06 2019-06-19 Аэромикс, Инк. Новые составы
PT3080134T (pt) * 2013-12-13 2018-11-08 Vertex Pharma Pró-fármacos de piridona amidas úteis como moduladores de canais de sódio
EP3218354A4 (en) 2014-11-13 2018-06-13 Aeromics, Inc. Novel methods

Also Published As

Publication number Publication date
US20190185496A1 (en) 2019-06-20
CA3022684A1 (en) 2017-11-16
KR20190005991A (ko) 2019-01-16
JP2022104995A (ja) 2022-07-12
IL262674A (en) 2018-12-31
JP2019521086A (ja) 2019-07-25
AU2017261828B2 (en) 2023-04-13
CN109475516A (zh) 2019-03-15
EP3454846A1 (en) 2019-03-20
US20240166673A1 (en) 2024-05-23
US11725018B2 (en) 2023-08-15
US20220204536A1 (en) 2022-06-30
MX2018013937A (es) 2019-08-12
TWI750169B (zh) 2021-12-21
BR112018073424A2 (pt) 2019-03-26
TW201741324A (zh) 2017-12-01
US11117909B2 (en) 2021-09-14
EP3454846A4 (en) 2019-12-11
RU2018144043A (ru) 2020-06-15
AU2017261828A1 (en) 2018-12-06
KR20230173224A (ko) 2023-12-26
CN115093443A (zh) 2022-09-23
WO2017197371A1 (en) 2017-11-16

Similar Documents

Publication Publication Date Title
RU2018144043A3 (ru)
BR112018003077A2 (ru)
CN303566625S (ru)
CN303572742S (ru)
CN303542623S (ru)
CN303542235S (ru)
CN303541195S (ru)
CN303539634S (ru)
CN303539396S (ru)
CN303539038S (ru)
CN303901526S (ru)
CN303537207S (ru)
CN303548714S (ru)
CN303550750S (ru)
CN303550812S (ru)
CN303551277S (ru)
CN303551586S (ru)
CN303552027S (ru)
CN303552156S (ru)
CN303552862S (ru)
CN303554014S (ru)
CN303555566S (ru)
CN303561943S (ru)
CN303564148S (ru)
CN303564232S (ru)